Breaking: FDA asks states to pause J & J vaccine due to blood clots in 6 women age 18 to 48.
J & J vaccine is an adenoviral vector vaccine, as is the Astra Zeneca vaccine
These unusual clots have NOT been seen with mRNA (Pfizer, Moderna) vaccines. cnbc.com/2021/04/13/us-…
I don't have the details of the 6 cases of thrombosis that prompted the recommendation. But it looks like the concern is the unusual combination of serious blood clots with low platelets in young people that prompted it. Not regular blood clots. @nytimesgoogle.com/amp/s/www.nyti…
The good news is that the US will maintain and reach vaccine related goals even without the J &J vaccine. @ASlavitt is quoted in this story @CNN.
Approximately 7 million doses of J & J vaccine have been given in the US. 6 cases of blood clots are being investigated.
IMPORTANT: The public should note that these clots have NOT been seen with Pfizer and Moderna vaccines after ~180 million doses. The vaccines are safe.
It's a real scientific puzzle why unusual blood clots have been seen with Astra Zeneca, an adenoviral vector vaccine; and now J&J another adenoviral vector vaccine.
Link to my thread on the blood clots seen with Astra Zeneca vaccine. Emphasizing that we don't know details of whether the 6 blood clots reported with J&J vaccine resemble the clinical picture seen with the Astra Zeneca vaccine. We should know more soon.
In light of what happened with the Astra Zeneca vaccine, considering the US has enough doses of Pfizer and Moderna, the FDA recommendation to pause the J&J vaccine is the right one.
Details on the type of clots seen with J&J vaccine.
61 year old man was diagnosed with Hodgkin Lymphoma. He then developed COVID. Only got supportive care. No steroids or immunotherapy. 4 months later, cancer had mostly resolved (left image vs right) 🪢
1) Hodgkin Lymphoma is unique among cancers in that what you see as big lumps of tumor are not cancer cells: Bulk of tumor mass is just normal reactive lymphocytes with small amounts of cancer (Reed Sternberg) cells mixed in. (Owl like cells)
So after COVID the reactive cells may disappear due to the severe viral infection, making it look like the cancer has gone into remission. But maybe only the normal reactive cells have disappeared. Time will tell if the true Hodgkin cancer cells are still there and will come back
Rare form of blood clots plus low platelets. ~60% involve veins of brain. Almost all after 1st dose.
Risk (UK MHRA): 1 in 250,000 people
Risk (EU EMA): 1 in 100,000 people
Risk of dying: 20-25% of people with these clots have died
Approximately half of the deaths in the UK (11 of 19) were under age 50.
The benefits of the Astra Zeneca vaccine according to regulators appear to outweigh risks in all except those less than age 30. bmj.com/content/373/bm…
While blood clots occur at a certain rate in population what is unusual about these clots is the association with low platelets. Platelets help make blood clots & when platelets are low we are at risk of bleeding not clotting.
Low platelets in context of blood clots is unusual.
Forget who did what wrong on the messaging. Just focus on the messages going forward.
Don't get stuck in debates of whether vaccines prevent transmission. They do reduce transmission dramatically. (It's will also be a largely moot question once 80% have been vaccinated).
Mortality rate of symptomatic COVID when healthcare system was overwhelmed early on (as in Italy, Spain, Belgium, & parts of the US) was incredibly high. As we flattened the curve & learnt to treat, the rate reduced to 2-3%.
It is indeed remarkable how across the world the mortality rate of confirmed, presumably symptomatic, COVID has coalesced to around 2-3%.
Although with improvements in treatment, mortality rates of symptomatic COVID may be lower that what we saw early last year in places that got overwhelmed, no country should be in a situation where the healthcare system is overwhelmed. That leads to much higher loss of life.
IFR can vary: by population characteristics, time period, availability of treatments, health system capabilities, etc.
But the death rate in the US, 1700 deaths per million, shows how devastating COVID can be in a rich country with supposedly the best healthcare resources of any